Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer

por Hiraide, Sakura, Takahashi, Masanobu, Yoshida, Yuya, Yamada, Hideharu, Komine, Keigo, Ishioka, Chikashi
Publicado 2021

lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma

por Yamada, Hideharu, Takahashi, Masanobu, Watanuki, Munenori, Watanabe, Mika, Hiraide, Sakura, Saijo, Ken, Komine, Keigo, Ishioka, Chikashi
Publicado 2021

lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma

por Yamada, Hideharu, Takahashi, Masanobu, Watanuki, Munenori, Watanabe, Mika, Hiraide, Sakura, Saijo, Ken, Komine, Keigo, Ishioka, Chikashi
Publicado 2021

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

por Takahashi, Masahiro, Takahashi, Masanobu, Komine, Keigo, Yamada, Hideharu, Kasahara, Yuki, Chikamatsu, Sonoko, Okita, Akira, Ito, Shukuei, Ouchi, Kota, Okada, Yoshinari, Imai, Hiroo, Saijo, Ken, Shirota, Hidekazu, Takahashi, Shin, Mori, Takahiro, Shimodaira, Hideki, Ishioka, Chikashi
Publicado 2017